权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

International Symposium on Dietary Therapies for Epilepsy and Other Neurological

癫痫及其他神经疾病饮食治疗国际研讨会

基本信息

批准号：
7485255
负责人：
Jong Min Rho
金额：
$ 1万
依托单位：
ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-04-01 至 2009-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7485255
关键词：
Accounting Adult Adverse effects Ally Alzheimer&apos s Disease Amyotrophic Lateral Sclerosis Anticonvulsants Area Basic Science Biochemical Brain Brain Neoplasms Caloric Restriction Carbohydrates Childhood Clinical Clinical Research Collaborations Condition Diet Dietary Factors Dietary Intervention Dietitian Disease Epilepsy Fasting Fatty acid glycerol esters Future Goals Growth Health Professional International Intervention Medical Surveillance Medical center Medicine Metabolic Molecular Nerve Degeneration Neurologic Neurologist Nurses Other Therapy Parkinson Disease Patients Pharmaceutical Preparations Pharmacotherapy Process Public Health Refractory Research Research Personnel Scientist Seizures Spinal cord injury Time United States Variant clinical effect day experience improved interest ketogenic diet multidisciplinary neglect nervous system disorder novel posters symposium

项目摘要

DESCRIPTION (provided by applicant): While most neurological disorders have traditionally been treated with pharmacological agents, there is growing evidence that dietary interventions can also exert beneficial clinical effects comparable to, or perhaps exceeding, drug therapy. This is especially true for the epilepsies which respond favorably to a high-fat low-carbohydrate diet known as the ketogenic diet. Indeed, following historical observations that fasting was effective for seizure control, clinicians formulated the ketogenic diet in the 1920's to mirror the biochemical changes seen in the fasted state. And although the ketogenic diet has been available since then in medical centers throughout the United States, it was not until this past decade that widespread international acceptance of this non-pharmacological intervention as an effective treatment for medically refractory epilepsy had been achieved. Scientific interest in the ketogenic diet has also paralleled the growth of clinical centers throughout the world, with the goal of understanding its underlying mechanisms of action - important information that is necessary to improve upon its clinical implementation. In the past several years, variations of the ketogenic diet have emerged as efficacious and better tolerated options in the treatment of epilepsy in both pediatric and adult patients. Additionally, there is a small but growing interest in treating other neurological disorders with dietary interventions - such as calorie restriction - that share some biochemical similarities with the KD. These conditions include Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, traumatic brain & spinal cord injury, and even brain tumors. That dietary factors should influence brain function is not altogether surprising, but it is important to note that such treatments can exert such profound clinical effects, where in many instances drugs have failed to produce lasting effects. A greater fundamental understanding of dietary and metabolic effects of brain function and disease processes is required to develop novel and effective strategies for what are often considered neurodegenerative and/or debilitating disorders. This symposium is aimed at neurologists, epileptologists, research scientists, nurses, dietitians, and other allied health professionals, with the fundamental goal of sharing up-to-date information on this rapidly expanding topic, and defining the important clinical and research questions that should be pursued in the future. Additionally, this symposium will provide a forum for extended discussions regarding practical clinical implementation, surveillance of adverse effects, and importantly, a critical look at basic cellular and molecular mechanisms that could account for the anticonvulsant and neuroprotective effects of the ketogenic diet. This symposium will be held over three full days, and will consist of both plenary sessions and mini- symposia, as well as poster and break-out sessions devoted to specific groups of healthcare professionals and researchers. While much of the focus of the symposium will be on dietary treatments for epilepsy, the final day will review our clinical and experimental experience with dietary therapies for other neurological disorders (including Alzheimer's and Parkinson's diseases, brain tumors and neurotrauma), paving the way toward a greater understanding of how dietary substrates, and the biochemical and metabolic consequences of their administration, can protect the diseased brain. An additional practical short-term goal will be to have attendees share information and establish clinical and research collaborations. It takes a multidisciplinary team to successfully implement the ketogenic diet, study it appropriately, and improve upon it. This spirit of cooperation constitutes the core rationale for this international symposium. PUBLIC HEALTH RELEVANCE: The fundamental goal of this symposium is to share up-to-date information on the rapidly expanding topic of dietary therapies for epilepsy, and to define the important clinical and research questions that should be pursued in the future. While there have been a few international meetings devoted to the topic of the KD, none have comprehensively examined both clinical and basic science aspects of this time-honored treatment. As such, we believe that this symposium may be the first landmark scientific meeting devoted to this long-neglected area of medicine.

描述（由申请人提供）：虽然大多数神经系统疾病传统上采用药物治疗，但越来越多的证据表明，饮食干预也可以发挥与药物治疗相当或可能超过药物治疗的有益临床效果。这对于癫痫患者尤其如此，癫痫患者对高脂肪低碳水化合物饮食（称为生酮饮食）反应良好。事实上，根据禁食对癫痫控制有效的历史观察，临床医生在20世纪20年代制定了生酮饮食，以反映禁食状态下观察到的生化变化。尽管生酮饮食从那时起就在美国各地的医疗中心提供，但直到过去十年，这种非药物干预作为医学难治性癫痫的有效治疗才得到广泛的国际认可。对生酮饮食的科学兴趣也促进了世界各地临床中心的发展，其目标是了解其潜在的作用机制-改善其临床实施所需的重要信息。在过去的几年中，生酮饮食的变化已经成为治疗儿童和成人患者癫痫的有效和更好的耐受性选择。此外，人们对通过饮食干预治疗其他神经系统疾病（如热量限制）的兴趣虽小但不断增长，这些疾病与KD有一些生化相似之处。这些疾病包括帕金森病、阿尔茨海默病、肌萎缩性侧索硬化症、创伤性脑和脊髓损伤，甚至脑肿瘤。饮食因素会影响大脑功能并不令人惊讶，但重要的是要注意到，这些治疗方法可以产生如此深远的临床效果，而在许多情况下，药物无法产生持久的效果。需要对脑功能和疾病过程的饮食和代谢影响有更深入的基本了解，以开发新的有效策略来治疗通常被认为是神经退行性和/或衰弱性疾病的疾病。本次研讨会的目标是神经学家，癫痫学家，研究科学家，护士，营养师和其他专职医疗人员，其基本目标是分享关于这一迅速发展的主题的最新信息，并确定未来应该追求的重要临床和研究问题。此外，本次研讨会将提供一个论坛，就实际的临床实施，监测不良反应，重要的是，在基本的细胞和分子机制，可以解释生酮饮食的抗惊厥和神经保护作用的批判性研究进行深入讨论。本次研讨会将持续三天，包括全体会议和小型研讨会，以及专门针对医疗保健专业人员和研究人员特定群体的海报和分组会议。虽然研讨会的重点将集中在癫痫的饮食治疗上，但最后一天将回顾我们在其他神经系统疾病饮食治疗方面的临床和实验经验（包括阿尔茨海默氏症和帕金森氏症，脑肿瘤和神经创伤），为更好地理解膳食基质，以及其管理的生化和代谢后果，可以保护患病的大脑另一个实际的短期目标是让与会者分享信息，建立临床和研究合作。生酮饮食的成功实施需要一个多学科的团队，适当地研究它，并对其进行改进。这种合作精神构成了这次国际研讨会的核心理念。公共卫生关系：本次研讨会的基本目标是分享关于癫痫饮食疗法这一迅速发展的主题的最新信息，并确定未来应追求的重要临床和研究问题。虽然有一些国际会议专门讨论KD的主题，但没有一个会议全面审查了这种历史悠久的治疗方法的临床和基础科学方面。因此，我们认为，这次研讨会可能是第一次具有里程碑意义的科学会议，专门讨论这一长期被忽视的医学领域。